Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design

G Bahr, LJ Gonzalez, AJ Vila - Chemical Reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …

NDM metallo-β-lactamases and their bacterial producers in health care settings

W Wu, Y Feng, G Tang, F Qiao… - Clinical microbiology …, 2019 - Am Soc Microbiol
New Delhi metallo-β-lactamase (NDM) is a metallo-β-lactamase able to hydrolyze almost all
β-lactams. Twenty-four NDM variants have been identified in> 60 species of 11 bacterial …

Alternatives to antibiotics—a pipeline portfolio review

L Czaplewski, R Bax, M Clokie, M Dawson… - The Lancet infectious …, 2016 - thelancet.com
Antibiotics have saved countless lives and enabled the development of modern medicine
over the past 70 years. However, it is clear that the success of antibiotics might only have …

Recent advance in oxazole-based medicinal chemistry

HZ Zhang, ZL Zhao, CH Zhou - European journal of medicinal chemistry, 2018 - Elsevier
Oxazole compounds containing nitrogen and oxygen atoms in the five-membered aromatic
ring are readily able to bind with a variety of enzymes and receptors in biological systems …

[HTML][HTML] Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors

R Wang, TP Lai, P Gao, H Zhang, PL Ho… - Nature …, 2018 - nature.com
Drug-resistant superbugs pose a huge threat to human health. Infections by
Enterobacteriaceae producing metallo-β-lactamases (MBLs), eg, New Delhi metallo-β …

β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs

C Gonzalez-Bello, D Rodríguez, M Pernas… - Journal of medicinal …, 2019 - ACS Publications
Infections caused by resistant bacteria are nowadays too common, and some pathogens
have even become resistant to multiple types of antibiotics, in which case few or even no …

Ten years with New Delhi metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design

P Linciano, L Cendron, E Gianquinto… - ACS infectious …, 2018 - ACS Publications
The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a
carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized …

β-lactam/β-lactamase inhibitor combinations: an update

KHME Tehrani, NI Martin - Medchemcomm, 2018 - pubs.rsc.org
Antibiotic resistance caused by β-lactamase production continues to present a growing
challenge to the efficacy of β-lactams and their role as the most important class of clinically …

Structural basis of metallo-β-lactamase inhibition by captopril stereoisomers

J Brem, SS van Berkel, D Zollman, SY Lee… - Antimicrobial agents …, 2016 - Am Soc Microbiol
ABSTRACT β-Lactams are the most successful antibacterials, but their effectiveness is
threatened by resistance, most importantly by production of serine-and metallo-β …

Dipicolinic acid derivatives as inhibitors of New Delhi metallo-β-lactamase-1

AY Chen, PW Thomas, AC Stewart… - Journal of medicinal …, 2017 - ACS Publications
The efficacy of β-lactam antibiotics is threatened by the emergence and global spread of
metallo-β-lactamase (MBL) mediated resistance, specifically New Delhi metallo-β-lactamase …